Auriga Partners
Venture Capital
Paris, France
172
11M
73
6.88
17
0.58
35
- Stages of investment
- Areas of investment
Summary
Auriga Partners is the famous VC, which was founded in 1998. The venture was found in Europe in France. The main department of described VC is located in the Paris.
Among the most successful fund investment fields, there are Medical Device, Medical. Besides, a startup requires to be at the age of 11-15 years to receive the investment from the fund. Among the most popular portfolio startups of the fund, we may highlight Nexthink, Ekinops, Hybrigenics. For fund there is a match between the location of its establishment and the land of its numerous investments - France. The fund has no specific favorite in a number of founders of portfolio startups. If startup sums 4 or 5+ of the founder, the chance for it to be financed is low.
The standard case for the fund is to invest in rounds with 3-4 partakers. Despite the Auriga Partners, startups are often financed by Omnes Capital, Bpifrance, XAnge. The meaningful sponsors for the fund in investment in the same round are Sofinnova Partners, Bpifrance, 123Venture. In the next rounds fund is usually obtained by Omnes Capital, 123Venture, Wellington Partners.
The fund is constantly included in 7-12 investment rounds annually. The top amount of exits for fund were in 2017. This Auriga Partners works on 9 percentage points less the average amount of lead investments comparing to the other organizations. The real fund results show that this VC is 12 percentage points less often commits exit comparing to other companies. The important activity for fund was in 2007. The common things for fund are deals in the range of 10 - 50 millions dollars.
This organization was formed by Bernard Daugeras, Jacques Chatain, Patrick Bamas. The overall number of key employees were 8.
Investor highlights
- Industry focus
- Stage focus
- Geo focus
Discover reliable insights
Find relevant VC investors, identify key contacts and secure funding opportunities.
Investments analytics
Analytics
- Total investments
- 172
- Lead investments
- 17
- Exits
- 35
- Rounds per year
- 6.88
- Follow on index
- 0.58
- Investments by industry
- Biotechnology (89)
- Health Care (62)
- Pharmaceutical (47)
- Manufacturing (41)
- Medical (33) Show 94 more
- Investments by region
-
- France (104)
- United States (33)
- Switzerland (13)
- Sweden (4)
- United Kingdom (7) Show 3 more
- Peak activity year
- 2009
- Number of Unicorns
- 1
- Number of Decacorns
- 1
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 19
- Avg. valuation at time of investment
- 99M
- Group Appearance index
- 0.74
- Avg. company exit year
- 17
- Avg. multiplicator
- 2.43
- Strategy success index
- 0.80
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
Company name | Deal date | Industry | Deal stage | Deal size | Location |
---|---|---|---|---|---|
Alyne | 27 Nov 2018 | Software, Information Technology, SaaS, Security, Consulting, Risk Management | Early Stage Venture | 3M | Munich, Bavaria, Germany |
Bag Tech | 01 Jul 2003 | Retail, Manufacturing, Lifestyle, AgTech | Early Stage Venture | 2M | Sialkot, Punjab, Pakistan |
Evolva | 11 Dec 2009 | Biotechnology, Food and Beverage, Health Care, Wellness, Consulting | Early Stage Venture | 17M | Switzerland, Aargau |
Similar funds
By same location
By same geo focus
By doing lead investments
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.